Chimerix, Inc. (CMRX)
NASDAQ: CMRX · IEX Real-Time Price · USD
0.900
0.00 (-0.01%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Chimerix Employees
Chimerix had 72 employees as of December 31, 2023. The number of employees decreased by 17 or -19.10% compared to the previous year.
Employees
72
Change (1Y)
-17
Growth (1Y)
-19.10%
Revenue / Employee
$569
Profits / Employee
-$1,147,111
Market Cap
80.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Protalix BioTherapeutics | 208 |
DBV Technologies | 105 |
BioAtla | 65 |
PMV Pharmaceuticals | 63 |
Ikena Oncology | 43 |
SCYNEXIS | 29 |
Genenta Science | 14 |
Nutriband | 13 |
CMRX News
- 16 days ago - Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update - GlobeNewsWire
- 3 months ago - Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024 - GlobeNewsWire
- 5 months ago - Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update - GlobeNewsWire
- 5 months ago - Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024 - GlobeNewsWire
- 7 months ago - Chimerix Appoints Lisa Decker to Board of Directors - GlobeNewsWire
- 8 months ago - Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer - GlobeNewsWire